23andMe Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:23andMe Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011288
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
23andMe Inc (23andMe) is a biotechnology research and information provider that offers tools for health and ancestry care. The company offers raw genetic data and ancestry-related genetic reports. It offers clinical development, research and development, ancestry services, commercialization services, and information of personal ancestry, genealogy and inherited traits. 23andMe’s ancestry services comprise ancestry composition, family tree tool, DNA relatives, maternal and paternal lineages, and neanderthal percentage. The company helps individuals to understand their genetic information using DNA analysis technologies and web-based interactive tools. It caters to students, clinicians, and developers. 23andMe is headquartered in Mountain View, California, the US.

23andMe Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
23andMe Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
23andMe Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
23andMe Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
23andMe Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
23andMe Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
23andMe Inc, Medical Equipment, Deal Details 10
Venture Financing 10
23andMe Raises USD250 Million in Venture Financing 10
Freenome Raises Additional USD7 Million in Series A Financing 12
Acquisition 13
23andMe Acquires CureTogether, Healthcare IT Company 13
23andMe Inc – Key Competitors 14
23andMe Inc – Key Employees 15
23andMe Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Strategy And Business Planning 17
Feb 10, 2016: 23andMe and Celmatix Collaborate to Improve Infertility Outcomes 17
Legal and Regulatory 18
Apr 06, 2017: 23andMe Granted First FDA Authorization to Market Direct-to-Consumer Genetic Health Risk Reports 18
Government and Public Interest 19
Feb 22, 2017: Celmatix and 23andMe Announce Launch of Fertility Research Community 19
Product News 20
Apr 06, 2017: FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions 20
Jul 13, 2016: 23andMe Launches New Genotyping Services for Research 22
Other Significant Developments 23
May 03, 2017: 23andMe and German Pain Specialist Grunenthal Explore the Genetics of Pain to Help Identify New Treatments for Patients 23
Jun 16, 2016: Illumina Announces Initial Customer Orders for the Global Screening Array 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
23andMe Inc, Medical Equipment, Key Facts 2
23andMe Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
23andMe Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
23andMe Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
23andMe Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
23andMe Inc, Deals By Market, 2011 to YTD 2017 8
23andMe Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
23andMe Raises USD250 Million in Venture Financing 10
Freenome Raises Additional USD7 Million in Series A Financing 12
23andMe Acquires CureTogether, Healthcare IT Company 13
23andMe Inc, Key Competitors 14
23andMe Inc, Key Employees 15
23andMe Inc, Subsidiaries 16

★海外企業調査レポート[23andMe Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Salzgitter AG:企業の戦略・SWOT・財務分析
    Salzgitter AG - Strategy, SWOT and Corporate Finance Report Summary Salzgitter AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • EMS SA:製薬・医療:M&Aディール及び事業提携情報
    Summary EMS SA (EMS) is a pharmaceutical company, which is focused in the development of products for improvement of health and well-being of the population. It operates in prescription segments generics, branded pharmaceuticals, OTC and hospital. It has presence in the US market through Brace Pharm …
  • Aduro BioTech Inc (ADRO):製薬・医療:M&Aディール及び事業提携情報
    Summary Aduro BioTech Inc (Aduro BioTech) is a clinical-stage immunotherapy company that discovers, develops and commercializes therapies for the treatment of cancer. The company develops product candidates using proprietary technology platforms such as live, attenuated, double-deleted listeria, sti …
  • QNB Finansbank (FINBN):企業の財務・戦略的SWOT分析
    QNB Finansbank (FINBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Globavir Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Globavir Biosciences Inc (Globavir) is a biotechnology company that develop combination of drug therapies and diagnostic tests in the therapeutic areas of infection and immune-oncology. The company develops Globavir’s Drug Discovery Platform (GDDP), which generates small molecule candidates …
  • Biocurv Medical Instruments, Inc.:企業の戦略・SWOT・財務情報
    Biocurv Medical Instruments, Inc. - Strategy, SWOT and Corporate Finance Report Summary Biocurv Medical Instruments, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Xintela AB (XINT):製薬・医療:M&Aディール及び事業提携情報
    Summary Xintela AB (Xintela) is a biomedical company that develops treatment for cartilage damage and brain tumors. The company’s technology includes Xinmark, a patented marker technology developed to identify and select certain types of tumor cells, which can develop into cartilage cells. It also p …
  • Xeltis AG:企業の製品パイプライン分析2018
    Summary Xeltis AG (Xeltis) is a clinical-stage medical equipment company that harnesses advances in science to improve the treatment of heart valve related conditions. The company’s polymer-based technology platform, RestoreX, facilitates the natural restoration of heart valve through a process refe …
  • Monster Beverage Corporation:企業の戦略・SWOT・財務情報
    Monster Beverage Corporation - Strategy, SWOT and Corporate Finance Report Summary Monster Beverage Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Codexis Inc (CDXS)-製薬・医療分野:企業M&A・提携分析
    Summary Codexis Inc (Codexis) is a biotechnology company, which focuses on the development of biocatalysts for commercial scale production of fine chemicals and pharmaceuticals. The company’s product portfolio includes pharmaceutical enzymes and intermediates, active pharmaceutical ingredients (APIs …
  • Arrogene Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Arrogene Inc (Arrogene) is a developer of cancer therapeutics and imaging products. The company develops nanomedicine products for the treatment of primary brain, lung, and triple negative breast cancer, and HER2-positive breast cancer and its metastasis. It offers cancer treatment technolog …
  • Petrobras Argentina S.A.:企業の戦略・SWOT・財務情報
    Petrobras Argentina S.A. - Strategy, SWOT and Corporate Finance Report Summary Petrobras Argentina S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Viralytics Ltd (VLA)-製薬・医療分野:企業M&A・提携分析
    Summary Viralytics Ltd (Viralytics), formerly Psiron Ltd is a provider of development and commercialisation of oncolytic immunotherapies. The company develops oncolytic immunotherapies for the treatment of different types of cancers. It offers cavataktm, a proprietary formulation for the common cold …
  • Dong-A Socio Holdings Co Ltd (000640):企業の財務・戦略的SWOT分析
    Dong-A Socio Holdings Co Ltd (000640) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Noni B Ltd (NBL):企業の財務・戦略的SWOT分析
    Noni B Ltd (NBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • ContraVir Pharmaceuticals Inc (CTRV)-製薬・医療分野:企業M&A・提携分析
    Summary ContraVir Pharmaceuticals Inc (ContraVir) is a biopharmaceutical company that focusses on development and commercialization of targeted antiviral therapies. The company’s pipeline product includes TXL, potent prodrug of antiviral tenofovir and CRV431 cyclophilin inhibitor that increases its …
  • Cegid Group SA:企業の戦略的SWOT分析
    Cegid Group SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Spanish National Cancer Research Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Spanish National Cancer Research Center (CNIO) is a medical research center that conducts cancer research programs. The center integrates basic and translational cancer research. It conducts various scientific programs, which include molecular oncology program, structural biology and biocomp …
  • Delta Electricity:企業の発電所・SWOT分析2018
    Delta Electricity - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • EDF Energy Holdings Ltd:企業の発電所・SWOT分析2018
    EDF Energy Holdings Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆